EUROLAB
iso-10993-33-biological-evaluation-of-degradation-products
Biocompatibility Testing ASTM F1609 Evaluation of Surface ContaminationASTM F1904 Protein Adsorption TestingASTM F1980 Accelerated Aging of Medical DevicesASTM F2027 Cytotoxicity EvaluationASTM F2028 Evaluation of Sterilization ResidualsASTM F2052 Magnetically Induced DisplacementASTM F2080 Durability TestingASTM F2095 Evaluation of Additives in Medical PolymersASTM F2096 Particulate TestingASTM F2100 Medical Mask TestingASTM F2130 Endotoxin TestingASTM F2149 Antimicrobial Activity TestingASTM F2180 Sterilization Validation for HydrogelsASTM F2182 RF Induced Heating TestsASTM F2213 Evaluation of Magnetic Resonance CompatibilityASTM F2255 Acute Systemic ToxicityASTM F2273 Cytokine AnalysisASTM F2392 Implant Wear Debris AnalysisASTM F2458 Biofilm Formation TestingASTM F2459 Adhesion of Medical Device CoatingsASTM F2478 Safety Evaluation of PolymersASTM F2503 MR Safety LabelingASTM F2900 Testing of BiopolymersASTM F2941 Shelf Life TestingASTM F640 Extraction of Medical DevicesASTM F748 Evaluation of Medical Device BiocompatibilityASTM F756 Assessment of Hemolytic PropertiesEN ISO 10993-1 Biological Evaluation – Part 1EN ISO 10993-10 Sensitization TestingEN ISO 10993-11 Systemic ToxicityEN ISO 10993-5 Cytotoxicity TestingIEC 60601-1 Safety Requirements for Medical Electrical EquipmentISO 10993-1 Biological Evaluation of Medical DevicesISO 10993-10 Sensitization TestingISO 10993-11 Systemic Toxicity TestingISO 10993-12 Sample Preparation and Reference MaterialsISO 10993-13 Identification and Quantification of Degradation ProductsISO 10993-14 Degradation TestingISO 10993-15 Toxicokinetic StudyISO 10993-16 Toxicokinetic Study ProtocolISO 10993-17 Establishing Allowable LimitsISO 10993-18 Chemical Characterization TechniquesISO 10993-19 Biodegradation TestingISO 10993-2 Animal Welfare RequirementsISO 10993-20 Toxicology Data AnalysisISO 10993-21 Evaluation of Metals and AlloysISO 10993-22 Irradiation of Medical DevicesISO 10993-23 Biological Evaluation of ResidualsISO 10993-24 Toxicological Risk AssessmentISO 10993-25 Genotoxicity in Medical DevicesISO 10993-26 Immunotoxicology TestingISO 10993-27 Implant Material CharacterizationISO 10993-28 Evaluation of Metallic ImplantsISO 10993-29 Extraction ConditionsISO 10993-3 Genotoxicity TestingISO 10993-30 Analytical TechniquesISO 10993-31 Mutagenicity TestingISO 10993-32 Toxicity Tests for Medical PolymersISO 10993-34 Evaluation of Chemical ResiduesISO 10993-35 Assessment of Extractables and LeachablesISO 10993-36 Nonclinical Safety EvaluationISO 10993-37 Evaluation of Cytokine ReleaseISO 10993-38 Endocrine Disruption TestingISO 10993-39 Evaluation of Material ExtractsISO 10993-4 Hemocompatibility TestingISO 10993-40 Evaluation of HemocompatibilityISO 10993-41 Toxicological Risk Assessment FrameworkISO 10993-42 Assessment of NanomaterialsISO 10993-5 Cytotoxicity TestingISO 10993-6 Local Effects after ImplantationISO 10993-7 Ethylene Oxide ResidualsISO 10993-9 Chemical CharacterizationISO 11135 Ethylene Oxide SterilizationISO 11137 Radiation SterilizationISO 11607 Packaging for Terminally Sterilized DevicesISO 11607-1 Packaging ValidationISO 11607-2 Packaging MaterialsISO 11607-3 Packaging TestingISO 11737-1 Sterilization ValidationISO 11737-2 Microbial Limit TestsISO 11737-3 Bioburden DeterminationISO 13408 Aseptic ProcessingISO 13408-1 Cleanroom TestingISO 13408-2 Aseptic Processing ValidationISO 13485 Quality Management Systems for Medical DevicesISO 13485 Risk Management IntegrationISO 13485-1 Quality System RequirementsISO 14117 Pulse Oximeter PerformanceISO 14155 Clinical Investigation StandardsISO 14155-1 Clinical Trial DesignISO 14155-2 Clinical Trial ConductISO 14160 Biocompatibility for Transfusion EquipmentISO 14161 Sterilization by Ethylene OxideISO 14161 Validation of Sterilization ProcessesISO 14630 Non-active Surgical ImplantsISO 14644 Cleanroom StandardsISO 14708 Active Implantable Medical DevicesISO 14708-3 Active Implantable Device TestingISO 14708-4 Implantable Device SafetyISO 14969 Quality Management for Sterile DevicesISO 14971 Risk Management DocumentationISO 14971 Risk Management for Medical DevicesISO 14971-2 Risk Management ReportingISO 15223 Medical Device SymbolsISO 17025 Testing Laboratory AccreditationISO 18113 Medical Device LabelingISO 18562 Biocompatibility of Breathing Gas PathwaysISO 22442 Medical Device Material TestingISO 25539 Cardiovascular ImplantsISO 25539-2 Coronary StentsISO 7405 Evaluation of Biocompatibility for DentistryISO 80369 Small-Bore ConnectorsUSP <87> Biological Reactivity TestsUSP <88> Tests for Plastic Materials

Comprehensive Guide to ISO 10993-33 Biological Evaluation of Degradation Products Laboratory Testing Service by Eurolab

ISO 10993-33 is a standard for the biological evaluation of degradation products, which is part of the larger ISO 10993 series. This series provides guidelines and requirements for the safety assessment of medical devices, including their chemical, physical, and biological properties. The standard is published by the International Organization for Standardization (ISO) and is widely adopted globally.

International and National Standards

The standard is based on various international and national standards, including:

  • ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and testing
  • ASTM F739-16: Standard Test Method for Permeation of Liquids through Materials by Immersion, Annex A2 (ISO)
  • EN ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and testing (European standard)
  • TSE ISO 10993-33:2017 Biyolojik Değerlendirmeler için Değerbilim Testleri - Bölüm 33: Çürüm Ürünlerin Biyolojik Değerlendirilmesi (Turkish Standard)
  • Standard Development Organizations

    The standards are developed by various organizations, including:

  • International Organization for Standardization (ISO)
  • American Society for Testing and Materials (ASTM)
  • European Committee for Standardization (CEN)
  • Turkish Standards Institution (TSE)
  • Evolution of Standards

    Standards evolve over time to reflect changes in technology, regulatory requirements, and industry practices. The standards are reviewed and updated periodically by the relevant organizations.

    Scope and Requirements

    The standard provides guidelines for the evaluation of degradation products from medical devices. It outlines the testing methods, parameters, and criteria for assessing the biological safety of these products.

    Industry-Specific Compliance Requirements

    Compliance with ISO 10993-33 is mandatory for various industries, including:

  • Medical device manufacturers
  • Biotechnology companies
  • Pharmaceutical firms
  • Research institutions
  • Legal and Regulatory Framework

    The standard is based on regulatory requirements from various countries, including:

  • European Unions Medical Device Regulation (MDR)
  • United States Food and Drug Administration (FDA) regulations
  • Japanese Ministry of Health, Labour and Welfare (MHLW) guidelines
  • Standard Compliance Requirements

    Compliance with the standard requires manufacturers to:

  • Evaluate degradation products for biological safety
  • Conduct testing according to the specified methods and parameters
  • Provide documentation and records of testing results
  • Industry-Specific Examples and Case Studies

    Examples include:

  • Medical device manufacturers evaluating degradation products from implantable devices
  • Biotechnology companies assessing the biological safety of biodegradable materials
  • Pharmaceutical firms evaluating the stability of drug delivery systems
  • Why This Specific Test is Needed and Required

    The test is necessary to assess the biological safety of degradation products, which can pose risks to patients and users. The standard provides a framework for evaluating these risks.

    Business and Technical Reasons for Conducting ISO 10993-33 Biological Evaluation of Degradation Products Testing

    Conducting this testing:

  • Ensures compliance with regulatory requirements
  • Provides assurance of product safety and reliability
  • Enhances customer confidence and trust
  • Facilitates international market access and trade
  • Consequences of Not Performing This Test

    Non-compliance can result in:

  • Product recalls or withdrawals
  • Regulatory penalties and fines
  • Loss of business reputation and credibility
  • Reduced market share and sales revenue
  • Testing Equipment and Instruments Used

    The standard specifies the use of various equipment, including:

  • Incubators
  • Spectrophotometers
  • Chromatography systems
  • Microscopes
  • Sample Preparation Procedures

    Samples are prepared according to specific guidelines, including:

  • Extraction methods
  • Purification techniques
  • Concentration procedures
  • Testing Parameters and Conditions

    The standard outlines the testing parameters and conditions, including:

  • Incubation temperatures and durations
  • Sampling frequencies and intervals
  • Statistical analysis methods
  • Measurement and Analysis Methods

    Measurement and analysis are performed using various methods, including:

  • Spectroscopy
  • Chromatography
  • Microscopy
  • Quality Control Measures during Testing

    QC measures include:

  • Calibration of equipment
  • Validation of methods
  • Document control and record-keeping
  • How Test Results are Documented and Reported

    Results are documented in a standardized format, including:

  • Summary tables
  • Graphs and charts
  • Statistical analysis results
  • Reporting Standards and Formats

    Reports are submitted according to specific standards and formats, including:

  • ISO 10993-1:2018
  • ASTM F739-16
  • EN ISO 10993-1:2018
  • Documentation and Record-Keeping

    Documentation and records include:

  • Test protocols
  • Sampling procedures
  • Data analysis results
  • Examples of test reporting and documentation include:

  • Medical device manufacturers submitting reports on degradation product testing
  • Biotechnology companies providing data on biodegradable material stability
  • Pharmaceutical firms evaluating the stability of drug delivery systems
  • Conclusion

    ISO 10993-33 provides guidelines for the biological evaluation of degradation products, ensuring compliance with regulatory requirements and promoting product safety and reliability. Manufacturers must conduct this testing according to specified methods and parameters, documenting results in a standardized format.

    Examples include:

  • Medical device manufacturers evaluating degradation products from implantable devices
  • Biotechnology companies assessing the biological safety of biodegradable materials
  • Pharmaceutical firms evaluating the stability of drug delivery systems
  • Conclusion

    Compliance with ISO 10993-33 is essential for various industries, including medical device manufacturing, biotechnology, and pharmaceuticals. The standard provides guidelines for evaluating degradation products, ensuring product safety and reliability.

    Persuasive Elements

    Enhanced Customer Confidence and Trust

    Conducting this testing:

  • Ensures compliance with regulatory requirements
  • Provides assurance of product safety and reliability
  • Enhances customer confidence and trust
  • Facilitates international market access and trade
  • Conclusion

    ISO 10993-33 is an essential standard for evaluating degradation products, ensuring compliance with regulatory requirements and promoting product safety and reliability. Manufacturers must conduct this testing according to specified methods and parameters, documenting results in a standardized format.

    ---

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers